Back to Trials
NCT05297734NARecruiting

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Stanford University

Start Date

6/24/2022

Completion Date

2/28/2028

Summary

This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.

Detailed Description

PRIMARY OBJECTIVES: I. Greater intervention effects on health-related quality of life SECONDARY OBJECTIVES: I. Greater intervention effects on patient activation II. Greater satisfaction with care and decision-making III. Greater documentation of goals of care and symptoms IV. To lower acute care V. Greater palliative care and hospice OUTLINE: Sites are randomized to 1 of 2 arms. ARM A: Patients receive educational materials to assist with advance care planning and symptom management through a technology-based supportive cancer care weekly during months 1-4 and every other week during months 5-12. ARM B: Patients are paired with a lay health worker who will discuss the same educational materials from ARM A either in person or by telephone discussions weekly during months 1-4 and every other week during months 5-12. All participants complete a baseline interview upon enrollment during the initial consent phone contact and then a survey at 3-, 6-and 12-months post enrollment.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: 1. Newly diagnosed patients with solid tumor cancer diagnosis or recurrence of the disease. 2. Patients must have the ability to understand and willingness to provide verbal consent. 3. Participants must speak English, Spanish, Chinese, or Vietnamese. Exclusion Criteria: 1. Inability to consent to the study 2. Plans to change oncologist within 12 months 3. Employed by the practice site 4. Patients who anticipate moving from the area within 12 months

Interventions

OTHER

Receive technology-based supportive cancer care

BEHAVIORAL

Receive redesigned team-based supportive cancer care

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

End of LifeCancer

Locations

University of Alabama at Birmingham

Birmingham, Alabama 35294

United States

University of South Alabama

Mobile, Alabama 36688

United States

Beckman Research Institute of City of Hope

Duarte, California 91010

United States

VA Medical Center, Fresno

Fresno, California 93703

United States

Santa Clara Valley Medical Center

Fruitdale, California 95128

United States

St Jude Heritage Medical Group

Fullerton, California 92835

United States

Oncology Institute for Hope and Innovation

Los Angeles, California 90017

United States

Sacramento VA Medical Center - VA Northern California Health Care System

Mather, California 95655

United States

Pacific Cancer Care

Monterey, California 93940

United States

VA Palo Alto

Palo Alto, California 94305

United States

Zuckerberg San Francisco General

San Francisco, California 94110

United States

Kaiser Foundation Research Institute

San Francisco, California 94115

United States

University of San Francisco

San Francisco, California 94117

United States

San Francisco VA Medical Center

San Francisco, California 94121

United States

Spark M. Matsunaga VA Medical Center

Honolulu, Hawaii 96819

United States

North Las Vegas VA Medical Center

Las Vegas, Nevada 89086

United States

George E. Wahlen Department of Veterans Affairs Medical Center

Salt Lake City, Utah 84148

United States